Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Ventas Inc. Common Stock (VTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Ventas Inc. Common Stock — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Ventas Inc. Common Stock trades at $80.12 (market cap $41.06B). The key difference: Ventas Inc. Common Stock is the larger of the two by market cap, and Ventas Inc. Common Stock pays the higher dividend (2.6%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Ventas Inc. Common Stock for 0 Days on average.
| RPRX | VTR | |
|---|---|---|
Market Cap | $25.27B | $41.06B |
Volume | 3,671,183 | 4,174,820 |
Sector | Health | Real Estate |
52-Week High | $63.96 | $100.53 |
52-Week Low | $35.44 | $67.45 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.50B | $53.78B |
Dividend Yield | 1.66% | 2.6% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Ventas Inc. Common Stock
Ventas is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, medical office buildings, and research-related facilities.
Read more on VTR →
